Podcast
The Next Trip with Altasciences and DevelRX
In this podcast episode, experts from Altasciences and DevelRX examine the preclinical, clinical, and regulatory requirements and strategies that second generation psychedelics may utilize to differentiate their pharmacological profile, and strategically demonstrate efficacy and safety data that may differentiate from first generation candidates. The discussion is moderated by Altasciences' Chief Scientific Officer, Dr. Beatrice Setnik.
The potential use of psychedelics for the treatment of various CNS indications is currently under active investigation.
The Many Faces of Recreational Drug Use - Episode 1
Drug addiction is a devastating condition that affects the quality of the user and their families. In this podcast series, we explore the behaviors of individuals who abuse opioids and stimulants, and learn about their patterns of use and motivations to compel them to continue using these drugs through a series of candid interviews with opioid and stimulant recreational drug users.